AngioDynamics cements No1 position in tissue ablation with Microsulis deal
This article was originally published in Clinica
Executive Summary
AngioDynamics has bolstered its presence in the tissue ablation market by investing $5m in microwave ablation device specialist Microsulis Medical, with an option to eventually buy the company. This sum gives AngioDynamics 14.3% of Microsulis's stock; it can purchase the company in full at any time until 22 September 2013.